Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Alzheimers/Dementia/Aging
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Alzheimer
Alzheimer's Association
Type of Organization: Charity
Email Address: grantsapp@alz.org
Funds Available for Clinical Trials: ✗ Research: ✔
Awards made through this joining initiative support investigators at every professional stage and are also designed to help talented scientists establish careers in Alzheimer’s and other neurodegenerative imaging research.
Submissions from collaborative research that have experience across aging and neurodegenerative diseases are strongly encouraged. Novel and creative ideas are sought, and proposals should also demonstrate feasibility.
Neuroradiologists and Neurologists (M.D., M.D./Ph.D, D.O.) and scientists (Ph.D) with faculty appointments are encouraged to apply, including instructor, assistant, associate and full professor levels.
Clinical neuroradiology fellows and post-doctoral fellows are eligible to apply as a principal investigator (PI) but must collaborate with an administrative PI who serves as the director of the laboratory in which the research will be conducted, who should have oversight of reporting requirements, if funded.
Training or mentoring-only proposals will not be considered.
Multidisciplinary teams are encourage to apply.
Note: Alzheimer’s Association grants are generally open to scientists and researchers across the globe; however, as a U.S.-based charity, the Alzheimer’s Association is subject to, and complies with, U.S. law. As a result, the Alzheimer’s Association cannot award, and will not award, grants in violation of applicable U.S. statutes and regulations. This means, among other things, that the Alzheimer’s Association cannot, and will not, fund any individual or entity (i) that is subject to U.S. comprehensive or targeted sanctions or if awarding funding would result in a violation of such sanctions, (ii) that is on the U.S. List of Specially Designated Nationals or entities owned or controlled by such persons, or (iii) when doing so is otherwise prohibited by U.S. laws related to combating terrorism.
Alzheimer's Association
Type of Organization: Charity
Email Address: grantsapp@alz.org
Funds Available for Clinical Trials: ✗ Research: ✔
Funding Details
Requirements: Eligibility requirementsAwards made through this joining initiative support investigators at every professional stage and are also designed to help talented scientists establish careers in Alzheimer’s and other neurodegenerative imaging research.
Submissions from collaborative research that have experience across aging and neurodegenerative diseases are strongly encouraged. Novel and creative ideas are sought, and proposals should also demonstrate feasibility.
Neuroradiologists and Neurologists (M.D., M.D./Ph.D, D.O.) and scientists (Ph.D) with faculty appointments are encouraged to apply, including instructor, assistant, associate and full professor levels.
Clinical neuroradiology fellows and post-doctoral fellows are eligible to apply as a principal investigator (PI) but must collaborate with an administrative PI who serves as the director of the laboratory in which the research will be conducted, who should have oversight of reporting requirements, if funded.
Training or mentoring-only proposals will not be considered.
Multidisciplinary teams are encourage to apply.
Note: Alzheimer’s Association grants are generally open to scientists and researchers across the globe; however, as a U.S.-based charity, the Alzheimer’s Association is subject to, and complies with, U.S. law. As a result, the Alzheimer’s Association cannot award, and will not award, grants in violation of applicable U.S. statutes and regulations. This means, among other things, that the Alzheimer’s Association cannot, and will not, fund any individual or entity (i) that is subject to U.S. comprehensive or targeted sanctions or if awarding funding would result in a violation of such sanctions, (ii) that is on the U.S. List of Specially Designated Nationals or entities owned or controlled by such persons, or (iii) when doing so is otherwise prohibited by U.S. laws related to combating terrorism.